Your pharma podcast production partner, built for a review-heavy industry.
Policy voice, market access credibility, and industry standing, on a schedule that plans for review instead of colliding with it.
We have produced podcasts for regulated and enterprise clients for 12 years. Your show gets built around scientific credibility, policy influence, and the industry relationships you need. The process is designed for high-stakes environments, so your experts can speak within your organization's own review requirements.
In this sector a podcast is not just content. It is how you shape the conversation on access and affordability, and how you put your scientific and policy expertise in front of the people who set the agenda.
Trusted by enterprise and pharma-adjacent brands
The kind of companies that trust us with their show.
Two things kill a pharma podcast. Only one of them is review.
The first is the calendar. Most agencies treat regulatory review as somebody else's problem to sort out after the recording is done. We build the production infrastructure and the release schedule around the review cycle you actually run. Your team gets the tools and the timeline to keep control of its own requirements.
The second is the part nobody warns you about. The pharma teams who have talked publicly about their shows say the same thing: the early episodes were too academic. Lilly called their own first attempt boring. Their ALS episode only landed once it was built around a patient's story instead of the science alone. A show that clears review and bores your audience has still failed.
The framework for scientific authority
Our work on Prescription for Better Access, an ongoing show for the pharma and market access industry, is where that discipline shows. We fit our production process to your internal MLR workflow, so your medical, legal, and regulatory teams see every detail before an episode reaches the public. There is no single "check" bolted on at the end. You get a production environment and a release schedule that account for real review cycles, so your scientific and policy voice can do its job. You keep the ultimate responsibility for regulatory standards and promotional compliance.
Book a Strategy Call →average MLR review cycle per job at mid and large pharmaceutical companies.
Prescription for Better Access has run continuously for the pharma and market access industry.
producing podcasts for enterprise, regulated, and life sciences clients since 2014.
across 3,000+ podcasts launched, so your show gets a team that has done this before.
What kind of show fits your organization?
Format usually comes down to two things: which audience you need, and what your review process does to each type of content. We help you pick one your team can actually sustain.
Policy and market access shows
Cover drug pricing, PBMs, and affordability policy. This is the exact format behind Prescription for Better Access, and it puts you inside the access conversation instead of talking around it.
Scientific storytelling
Put your researchers and R&D teams on the science behind a therapeutic area. Done well it builds standing with clinicians, investigators, and scientific media. Done as a lecture it is the format most likely to bore your audience, so it lives or dies on the story you build it around.
Medical affairs and industry commentary
A recurring show for medical affairs teams and business development audiences tracking industry trends, policy shifts, and the competitive landscape.
Internal and R&D communications
Private, restricted-access shows for your scientific teams and for internal updates across sites and functions. Distributed like a public show, but only to the people it is meant for.
Build the package that fits your organization. One production partner.
These are the pieces your show can be built from. Take the full stack or pick only what you need. Either way it stays with one team, and your review windows go into the schedule instead of getting discovered mid-production.
Podcast Launch
An end-to-end launch that maps your internal review timeline into the schedule from day one. A 50-day review cycle is not a surprise the week before your first episode airs.
Learn moreAudio Production
Degree-trained engineers edit, mix, and master every episode in three to five business days. That is the consistency a long-running show like Prescription for Better Access needs.
Learn moreVideo Production
YouTube-ready cuts and short-form clips from every recording, delivered through the same review workflow as your audio so nothing publishes ahead of your sign-off.
Learn morePodcast Management
A dedicated producer runs your show week to week, scheduling around review submission windows and medical affairs calendars instead of fighting them.
Learn morePodcast Marketing
Audiograms, videograms, and full episode transcripts from every recording, ready for your team to route through review before publishing. Transcripts also make your show readable to search and AI answer engines. Audio alone never is.
Learn morePrivate & Public Hosting
Public distribution to Apple, Spotify, and YouTube for industry-facing shows, or private, restricted-access hosting for internal medical affairs and R&D communication.
Learn morePrescription for Better Access, produced episode after episode.
Mark Hansan and Dr. Scott Howell co-host Prescription for Better Access, covering drug pricing, PBMs, patient access, and FDA policy for pharma, biotech, and market access audiences. We have produced it continuously since its 2023 launch, including live episodes recorded at industry events like Asembia's AXS Summit.
Book a Strategy Call →With pharmaceutical and biotech manufacturers launching more high-cost specialty drugs, two industry veterans have joined forces to co-host an interview-focused podcast to help shape the future of patient access and affordability.
See what your show could sound like.
A real, ongoing pharma industry client, alongside practitioner and enterprise formats that translate to medical affairs and R&D audiences.
Prescription for Better Access
A recurring interview show co-hosted by Mark Hansan and Dr. Scott Howell, covering drug pricing, PBMs, patient access, and FDA policy for a pharma and biotech audience. We have produced it since its 2023 launch.
This is our clearest pharma credential. It is a real, ongoing client show, built for the exact policy and market access audience this page is written for.
Listen on Apple Podcasts →Shared Practices, Your Dental Roadmap
A practitioner-focused show for dental professionals working through ownership, growth, and transition. We have produced it since launch, and it has built a loyal, returning audience in its niche.
Different field, same mechanic. This is the practitioner deep-dive format, and it is how you build standing with a clinical or scientific audience over time rather than in one campaign.
Listen on Apple Podcasts →Better by Great Place to Work
A branded podcast for Great Place to Work, the global authority on workplace culture. It interviews executives and people leaders on building high-trust workplaces. We produce and manage it end to end.
This is the internal-communications model you would use for R&D team storytelling and employee-facing content across sites.
Listen on Apple Podcasts →Ready to build a show your review team can plan around?
Thirty minutes. We talk through your audience, your internal review process, and what a production schedule looks like for your organization.
Common questions about pharma and biotech podcast production.
Everything worth knowing before you start or scale a show for your organization.
Book a Strategy Call →What is a pharma or biotech podcast?+
Why do most pharma podcasts fail?+
How does MLR review affect a pharma podcast schedule?+
What does a pharma podcast production agency do?+
Who is responsible for regulatory compliance on a pharma podcast?+
What kind of podcast should a pharma or biotech company launch?+
How much does pharma podcast production cost?+
How is a pharma podcast different from a general branded podcast?+
Has Resonate produced podcasts for pharma or biotech organizations specifically?+
The access conversation is happening without you.
Let's build a show that puts you in it.
Book a thirty-minute strategy call. We talk through your audience, your internal review process, and what a pharma podcast looks like for your organization.
No commitment. Thirty minutes. Honest advice about whether podcasting is right for your organization right now.